Program Goals

Comparison of Incretin-based Agents

Available FDA-Approved GLP-1 Receptor Agonists

GLP-1 Receptor Agonists: Side Effects and Precautions

Reasons for Initiating Insulin Therapy

AACE Glycemic Control Algorithm

Scientific Logic of Combining Basal Insulin With a GLP-1 Receptor

Agonist

GLP-1 Receptor Agonists in Development

New Insulins in Development

GLP-1-Insulin Fixed-Dose Combination

Closing Comments

Abbreviations

References

References (cont)

References (cont)